Oric Pharmaceuticals, Inc. — 10-Q Filings
18 10-Q filings on record
This page lists all 10-Q filings submitted to the SEC by Oric Pharmaceuticals, Inc. (ORIC), sorted by most recent first. Each row links to the full filing on EdgarLookup. Oric Pharmaceuticals, Inc. has filed 18 10-Q documents with the SEC since 2019. To view all SEC filings by Oric Pharmaceuticals, Inc., see the full filings list.
All
10-K
10-Q
144
3
4
4/A
424B3
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
POS AM
POSASR
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-I
SC TO-I/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-Q | 10-Q | 0001193125-25-280234 | Nov 13, 2025 | Sep 30, 2025 |
| 10-Q | 10-Q | 0000950170-25-107359 | Aug 12, 2025 | Jun 30, 2025 |
| 10-Q | 10-Q | 0000950170-25-063564 | May 5, 2025 | Mar 31, 2025 |
| 10-Q | 10-Q | 0000950170-24-125471 | Nov 12, 2024 | Sep 30, 2024 |
| 10-Q | 10-Q | 0000950170-24-095467 | Aug 12, 2024 | Jun 30, 2024 |
| 10-Q | 10-Q | 0000950170-24-053582 | May 6, 2024 | Mar 31, 2024 |
| 10-Q | 10-Q | 0000950170-23-059415 | Nov 6, 2023 | Sep 30, 2023 |
| 10-Q | 10-Q | 0000950170-23-041362 | Aug 10, 2023 | Jun 30, 2023 |
| 10-Q | 10-Q | 0000950170-23-018839 | May 8, 2023 | Mar 31, 2023 |
| 10-Q | 10-Q | 0000950170-22-022631 | Nov 7, 2022 | Sep 30, 2022 |
| 10-Q | 10-Q | 0000950170-22-016894 | Aug 11, 2022 | Jun 30, 2022 |
| 10-Q | 10-Q | 0000950170-22-008512 | May 9, 2022 | Mar 31, 2022 |
| 10-Q | 10-Q | 0000950170-21-003477 | Nov 8, 2021 | Sep 30, 2021 |
| 10-Q | 10-Q | 0000950170-21-001185 | Aug 10, 2021 | Jun 30, 2021 |
| 10-Q | 10-Q | 0001564590-21-024997 | May 6, 2021 | Mar 31, 2021 |
| 10-Q | 10Q | 0001564590-20-051363 | Nov 5, 2020 | Sep 30, 2020 |
| 10-Q | 10-Q | 0001564590-20-036836 | Aug 5, 2020 | Jun 30, 2020 |
| 10-Q | 10-Q | 0001564590-20-026394 | May 20, 2020 | Mar 31, 2020 |